Express delivery and free returns within 21 days

Friday, July 1, 2022

MEDICAL DEVICE NEWS MAGAZINE

|

Contact us 561.316.3330

KARL STORZ and Saphena Medical Partnership

Companies to Provide Integrated Solutions for EVH Procedures

KARL STORZ Endoscopy-America, Inc., announced a new partnership with Saphena Medical to provide advanced instruments for endoscopic vessel harvesting (EVH).

EVH is a revolutionary procedure that enables surgeons to obtain grafts for coronary bypass using a keyhole approach, without lengthy incisions. Dr. Albert Chin, the co-founder of Saphena Medical, pioneered the technology, which has enjoyed rapid and widespread adoption in the field. The introduction of Saphena’s Venapax® device represented a major advance by enabling the surgeon to dissect, ligate, and extract a vessel with a single instrument.

The 4th generation Venapax has been specifically constructed with a reinforced shaft and internal guides to fit a KARL STORZ telescope. It allows for a simplified radial artery or saphenous vein harvesting with a shortened learning curve and a drastically reduced overall disposable cost. The partnership began with a pilot program at five hospitals and will continue to expand on a phased basis.

“We are excited to join forces with such a dynamic and innovative partner. Our expertise in endoscopic imaging—which includes considerable experience in the cardiothoracic market—makes us the logical choice for advancing this EVH technology,” said Monica Ambrose, Executive Director of Surgical Marketing at KARL STORZ.

Subscribe to Medical Device News Magazine
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing

Funds will be used to complete the first-in-human clinical study in Australia of the SirPlux Duo drug-coated balloon in de-novo coronary artery disease lesions notes Advanced NanoTherapies.

Centerline Biomedical Raises $33 Million in Series B Financing

Centerline Biomedical notes their flagship product, IOPS® (Intra-Operative Positioning System) was developed in Cleveland Clinic's Heart and Vascular Institute and utilizes patented algorithms to generate a patient-specific vascular map combined with electromagnetic tracking and smart sensor-equipped surgical devices to provide real-time, 3-D color visualization and navigation of the human vascular system.

MicroTransponder Raises $53M

MicroTransponder plans to use the funds to commercialize the Vivistim® Paired VNS™ System and establish it as the recommended rehabilitation intervention for stroke survivors working to improve their quality of life through more hand and arm mobility.

By using this website you agree to accept Medical Device News Magazine Privacy Policy